{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:12:10Z","timestamp":1778915530352,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,7]],"date-time":"2027-05-07T00:00:00Z","timestamp":1809648000000},"content-version":"am","delay-in-days":279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jocn.2026.112062","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:14:35Z","timestamp":1778123675000},"page":"112062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Risk factors associated with ischemic stroke during temporary oral anticoagulant interruption in patients with non-valvular atrial fibrillation"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3724-8139","authenticated-orcid":false,"given":"Nobuaki","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Korai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuishin","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2026.112062_b0005","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"RE-LY steering committee and investigators. Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2026.112062_b0010","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"ROCKET AF investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2026.112062_b0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"ARISTOTLE committees and investigators. Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2026.112062_b0020","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"ENGAGE AF-TIMI 48 investigators. Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2026.112062_b0025","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaneurol.2025.1337","article-title":"Residual risk of recurrent stroke despite anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"82","author":"McCabe","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jocn.2026.112062_b0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jamaneurol.2024.1892","article-title":"Recurrentischemicstrokein patients with atrial fibrillation while receiving oral anticoagulants","volume":"81","author":"Hindsholm","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jocn.2026.112062_b0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/00325481.2015.1074032","article-title":"Discontinuation of oral anticoagulation preceding acute ischemic stroke\u2013prevalence and outcomes: comprehensive chart review","volume":"127","author":"Vanga","year":"2015","journal-title":"Postgrad Med"},{"issue":"10482","key":"10.1016\/j.jocn.2026.112062_b0040","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","article-title":"PRESTIGE-AF consortium","volume":"405","author":"Veltkamp","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2026.112062_b0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/heartjnl-2020-317887","article-title":"Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemicstroke","volume":"107","author":"Rodr\u00edguez","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jocn.2026.112062_b0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/rth2.12076","article-title":"Perioperative interruption of direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta\u2010analysis","volume":"2","author":"Shaw","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jocn.2026.112062_b0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2024.12708","article-title":"Perioperative management of patients taking direct oral anticoagulants: a review","volume":"332","author":"Douketis","year":"2024","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jocn.2026.112062_b0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5853\/jos.2023.03279","article-title":"Cancer-associatedstroke:thrombosismechanism,diagnosis,outcome, andtherapeuticstrategies","volume":"26","author":"Heo","year":"2024","journal-title":"J Stroke"},{"issue":"70","key":"10.1016\/j.jocn.2026.112062_b0065","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Riskofarterialthromboembolisminpatientswithcancer","volume":"22","author":"Navi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jocn.2026.112062_b0070","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2026.112062_b0075","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jocn.2026.112062_b0080","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jocn.2026.112062_b0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2026.112062_b0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:43:32Z","timestamp":1778913812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826002134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"alternative-id":["S0967586826002134"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112062","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors associated with ischemic stroke during temporary oral anticoagulant interruption in patients with non-valvular atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112062"}}